Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Polyethylene glycol
Drug ID BADD_D02476
Description Polyethylene glycol (PEG) is a synthetic polymer produced via polymerization of ethylene oxide molecules to make joining units of ethylene glycol by an ether linkage.[A190975,A190978] PEGs are water-soluble polymers that can form hydrogen bonds in a ratio of 100 water molecules per one PEG molecule.[A190975] Molecular weights of PEGs vary by time of the polymerization process and the molecular weight represents the weighted average of the individual PEG molecules. PEGs differ in their physical and chemical properties depending on their molecular weight: PEGs are liquids when molecular weights are <1000 and the molecule turns to waxy solids with increasing molecular weights.[A190978] The most common preparations of PEGs include PEG 3350 and PEG 400. PEGs have various applications in many fields, ranging from medical to industrial areas. PEGs have a long history of gastroenterology: PEG 3350 is a common over-the-counter osmotic laxative used to relieve occasional constipation.[L11812] PEG 3350 is also used for cleansing of the colon in preparation for colonoscopy in adults.[L6421] The rationale of using PEG in gastroenterology is due to the physical properties of the compound: its potent water-binding capacity, negligible intestinal absorption with increasing molecular mass, lack of significant toxicity, and limited intestinal enzymatic degradation or bacterial metabolism all make PEG a useful therapeutic agent for the treatment of occasional constipation and bowel cleansing for preparation in colonoscopy.[A18713]
Indications and Usage Used to treat and prevent constipation.
Marketing Status Not Available
ATC Code A06AD15
DrugBank ID DB09287
KEGG ID D03370
MeSH ID D011092
PubChem ID 174
TTD Drug ID D0IV3M
NDC Product Code 68001-505; 59044-0009
Synonyms Polyethylene Glycols | Macrogol | Macrogols | Polyethylene Oxide | Oxide, Polyethylene | Oxides, Polyethylene | Polyethylene Oxides | Polyethyleneoxide | Polyethyleneoxides | Polyoxyethylenes | Polyoxyethylene | Polyglycol | Polyglycols | Polyethylene Glycol | Glycol, Polyethylene | Glycols, Polyethylene | Carbowax
Chemical Information
Molecular Formula C2H6O2
CAS Registry Number 107-21-1
SMILES C(CO)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dysgeusia17.02.07.003; 07.14.03.0010.001002%
Dyspepsia07.01.02.0010.000334%
Dyspnoea22.02.01.004; 02.01.03.002--
Dysuria20.02.02.0020.000334%
Erythema23.03.06.0010.000334%Not Available
Eye swelling06.08.03.0030.000334%Not Available
Faeces hard07.01.03.0030.000501%Not Available
Fatigue08.01.01.002--
Feeling abnormal08.01.09.0140.000668%Not Available
Flatulence07.01.04.0020.001002%
Fluid overload14.05.06.001; 02.05.04.0040.000334%Not Available
Foreign body aspiration22.02.07.008; 12.01.03.0010.000334%Not Available
Frequent bowel movements07.02.04.0020.000668%Not Available
Gait disturbance08.01.02.002; 17.02.05.0160.000668%
Gastrointestinal disorder07.11.01.0010.000334%Not Available
Generalised oedema14.05.06.007; 08.01.07.0040.000334%
Generalised tonic-clonic seizure17.12.01.0020.000668%Not Available
Haematocrit decreased13.01.05.0010.000334%Not Available
Haemoglobin decreased13.01.05.0030.000334%Not Available
Headache17.14.01.0010.001169%
Hydronephrosis20.01.05.0010.000334%Not Available
Hyperhidrosis23.02.03.004; 08.01.03.0280.000334%
Hypersensitivity10.01.03.0030.000501%
Hypoaesthesia17.02.06.0230.000835%Not Available
Hyponatraemia14.05.04.0020.001002%
Hypotension24.06.03.0020.000334%
Lethargy19.04.04.004; 17.02.04.003; 08.01.01.0080.000334%
Loss of consciousness17.02.04.0040.000501%Not Available
Malaise08.01.01.003--
Migraine24.03.05.003; 17.14.02.0010.000334%Not Available
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages